 send to a friend by email
2024-11-17
According to the financial statements of Jerusalem Pharmaceuticals Company JPH for the first nine months of 2024, Net profit after tax of the period reached 2,569,215 USD Compared with Net profit after tax 5,419,186 USD for 2023, a net decrease in profit of 52.59%.Total assets of the company reached 84,305,650 USD compared with total assets of 86,320,946 USD at the end of year 2023, a net decrease of 2.33%.Total liabilities of the company reached 16,693,627 USD compared with total liabilities of 17,442,878 USD at the end of year 2023, a net decrease of 4.29%. Net ownership equity of the company reached 67,612,023 USD (Including Non-Controlling Interests of 958,814 USD) compared with total owner equity of 68,878,068 USD (Including Non-Controlling Interests of 1,037,498 USD) at the end of year 2023, a net decrease of 1.84%.
|
-trade
